The global protein nanoparticle labeling reagent market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for protein nanoparticle labeling reagents in various applications such as cel-based assays, fluorescence microscopy, immunological techniques, mass spectrometry and protein microarray. The enzymes segment accounted for the largest share of the global protein nanoparticle labeling reagent market in 2018 and is expected to continue its dominance throughout the forecast period. The enzymes segment was followed by monoclonal antibodies and probes/tags segments which are also expected to grow at a significant rate during the forecast period.
Some Of The Growth Factors Of This Market:
- The increasing demand for protein nanoparticle labeling reagent is a major factor driving the growth of the market.
- The increasing number of research and development activities in the field of protein nanoparticle labeling reagent is also a major factor driving the growth of this market.
- The growing awareness about protein nanoparticle labeling reagents among researchers and scientists is also a major factor driving the growth of this market.
- The rising number of collaborations between companies in order to develop new products for protein nanoparticle labeling reagent is another key driver for this market's growth.
- Increasing government funding on research and development activities related to protein nanoparticles are also one of the factors that are expected to drive this market's growth.
Industry Growth Insights published a new data on “Protein Nanoparticle Labeling Reagent Market”. The research report is titled “Protein Nanoparticle Labeling Reagent Market research by Types (Enzymes, Monoclonal Antibodies, Probes/Tags, Protein, Others), By Applications (Cell-based Assays, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry, Protein Microarray), By Players/Companies Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), General Electric Company (U.S.), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs (U.S.), Kaneka Corporation (Japan), Promega Corporation (U.S.), LI-COR, Inc. (U.S.), SeraCare Life Sciences, Inc. (U.S.)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Protein Nanoparticle Labeling Reagent Market Research Report
By Type
Enzymes, Monoclonal Antibodies, Probes/Tags, Protein, Others
By Application
Cell-based Assays, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry, Protein Microarray
By Companies
Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), General Electric Company (U.S.), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs (U.S.), Kaneka Corporation (Japan), Promega Corporation (U.S.), LI-COR, Inc. (U.S.), SeraCare Life Sciences, Inc. (U.S.)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Protein Nanoparticle Labeling Reagent Market Report Segments:
The global Protein Nanoparticle Labeling Reagent market is segmented on the basis of:
Types
Enzymes, Monoclonal Antibodies, Probes/Tags, Protein, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cell-based Assays, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry, Protein Microarray
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific, Inc. (U.S.)
- Merck KGaA (Germany)
- PerkinElmer, Inc. (U.S.)
- General Electric Company (U.S.)
- F. Hoffmann-La Roche AG (Switzerland)
- New England Biolabs (U.S.)
- Kaneka Corporation (Japan)
- Promega Corporation (U.S.)
- LI-COR, Inc. (U.S.)
- SeraCare Life Sciences, Inc. (U.S.)
Highlights of The Protein Nanoparticle Labeling Reagent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Enzymes
- Monoclonal Antibodies
- Probes/Tags
- Protein
- Others
- By Application:
- Cell-based Assays
- Fluorescence Microscopy
- Immunological Techniques
- Mass Spectrometry
- Protein Microarray
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Protein Nanoparticle Labeling Reagent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Protein nanoparticle labeling reagent is a chemical that can be used to label proteins with specific identifiers. This allows for the identification and tracking of proteins in experiments.
Some of the key players operating in the protein nanoparticle labeling reagent market are Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), General Electric Company (U.S.), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs (U.S.), Kaneka Corporation (Japan), Promega Corporation (U.S.), LI-COR, Inc. (U.S.), SeraCare Life Sciences, Inc. (U.S.).
The protein nanoparticle labeling reagent market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Protein Nanoparticle Labeling Reagent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Protein Nanoparticle Labeling Reagent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Protein Nanoparticle Labeling Reagent Market - Supply Chain
4.5. Global Protein Nanoparticle Labeling Reagent Market Forecast
4.5.1. Protein Nanoparticle Labeling Reagent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Protein Nanoparticle Labeling Reagent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Protein Nanoparticle Labeling Reagent Market Absolute $ Opportunity
5. Global Protein Nanoparticle Labeling Reagent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Type
5.3.1. Enzymes
5.3.2. Monoclonal Antibodies
5.3.3. Probes/Tags
5.3.4. Protein
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Protein Nanoparticle Labeling Reagent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Application
6.3.1. Cell-based Assays
6.3.2. Fluorescence Microscopy
6.3.3. Immunological Techniques
6.3.4. Mass Spectrometry
6.3.5. Protein Microarray
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Protein Nanoparticle Labeling Reagent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Protein Nanoparticle Labeling Reagent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Protein Nanoparticle Labeling Reagent Demand Share Forecast, 2019-2026
9. North America Protein Nanoparticle Labeling Reagent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Application
9.4.1. Cell-based Assays
9.4.2. Fluorescence Microscopy
9.4.3. Immunological Techniques
9.4.4. Mass Spectrometry
9.4.5. Protein Microarray
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Type
9.7.1. Enzymes
9.7.2. Monoclonal Antibodies
9.7.3. Probes/Tags
9.7.4. Protein
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Protein Nanoparticle Labeling Reagent Demand Share Forecast, 2019-2026
10. Latin America Protein Nanoparticle Labeling Reagent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Application
10.4.1. Cell-based Assays
10.4.2. Fluorescence Microscopy
10.4.3. Immunological Techniques
10.4.4. Mass Spectrometry
10.4.5. Protein Microarray
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Type
10.7.1. Enzymes
10.7.2. Monoclonal Antibodies
10.7.3. Probes/Tags
10.7.4. Protein
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Protein Nanoparticle Labeling Reagent Demand Share Forecast, 2019-2026
11. Europe Protein Nanoparticle Labeling Reagent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Application
11.4.1. Cell-based Assays
11.4.2. Fluorescence Microscopy
11.4.3. Immunological Techniques
11.4.4. Mass Spectrometry
11.4.5. Protein Microarray
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Type
11.7.1. Enymes
11.7.2. Monoclonal Antibodies
11.7.3. Probes/Tags
11.7.4. Protein
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Protein Nanoparticle Labeling Reagent Demand Share, 2019-2026
12. Asia Pacific Protein Nanoparticle Labeling Reagent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Application
12.4.1. Cell-based Assays
12.4.2. Fluorescence Microscopy
12.4.3. Immunological Techniques
12.4.4. Mass Spectrometry
12.4.5. Protein Microarray
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Type
12.7.1. Enzymes
12.7.2. Monoclonal Antibodies
12.7.3. Probes/Tags
12.7.4. Protein
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Protein Nanoparticle Labeling Reagent Demand Share, 2019-2026
13. Middle East & Africa Protein Nanoparticle Labeling Reagent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Application
13.4.1. Cell-based Assays
13.4.2. Fluorescence Microscopy
13.4.3. Immunological Techniques
13.4.4. Mass Spectrometry
13.4.5. Protein Microarray
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Protein Nanoparticle Labeling Reagent Market Size and Volume Forecast by Type
13.7.1. Enzymes
13.7.2. Monoclonal Antibodies
13.7.3. Probes/Tags
13.7.4. Protein
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Protein Nanoparticle Labeling Reagent Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Protein Nanoparticle Labeling Reagent Market: Market Share Analysis
14.2. Protein Nanoparticle Labeling Reagent Distributors and Customers
14.3. Protein Nanoparticle Labeling Reagent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher Scientific, Inc. (U.S.)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck KGaA (Germany)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. PerkinElmer, Inc. (U.S.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. General Electric Company (U.S.)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. F. Hoffmann-La Roche AG (Switzerland)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. New England Biolabs (U.S.)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Kaneka Corporation (Japan)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Promega Corporation (U.S.)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. LI-COR, Inc. (U.S.)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. SeraCare Life Sciences, Inc. (U.S.)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook